MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for Jasper Therapeutics, Inc. Voting Common Stock (JSPR)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Jasper Therapeutics, Inc. Voting Common Stock
Symbol
JSPR
Shares outstanding
28,139,786 shares
Disclosed Ownership
1,969,785 shares
Ownership
7%
Form type
SCHEDULE 13G
Filing time
11 Feb 2026, 13:38:43 UTC
Date of event
31 Dec 2025
Previous filing
07 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7% 1,969,785 0 1,969,585 Chris O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 6.8% 1,903,420 0 1,903,420 Chris O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC